Organization: Health Canada
Year: 2023
Month: June
Request Number: A-2022-001208
Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practices (GMP) inspection of the Elanco Canada facility (Site A) on Minnesota Ct, Mississauga, Ontario, starting around 08/03/2022. Reference Number 502718.
Disposition: Disclosed in part
Number of pages: 24